Join
Live feed
·
SECFilingvia Quantisnow
Clarus Therapeutics Holdings Inc. logo

Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
CRXT· Clarus Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRXT (Clarus Therapeutics Holdings Inc.) and more on Quantisnow.